Omada Health, Inc. (NASDAQ:OMDA)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Profitable, but on a thin margin.
- Revenue
- $309.8M
- Net income
- $4.3M
- Net margin
- 1.4%
Little or no net debt.
- Total debt
- $0
- Cash
- $221.7M
- Net debt / EBITDA
- -21.64x
Comfortably covers what is due within a year.
- Current assets
- $294.9M
- Current liabilities
- $75.5M
- Current ratio
- 3.91
The business funds itself from operations.
- Operating cash flow
- $23.7M
- Free cash flow
- $22.8M
- FCF margin
- 7.3%
Not funding itself by issuing shares.
- Shares outstanding
- 59.7M
- Share growth (1y)
- 4.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
OMDA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 87.83 M | 78.05 M | 75.85 M | 68.03 M | 61.37 M | 54.96 M |
| Revenue Growth (YoY) | 43.12 % | 42.00 % | 58.08 % | 49.47 % | 48.92 % | 56.61 % |
| Cost of Revenue | 24.05 M | 29.36 M | 22.18 M | 22.96 M | 21.19 M | 23.06 M |
| Gross Profit | 63.79 M | 48.69 M | 53.66 M | 45.07 M | 40.18 M | 31.90 M |
| SG&A Expense | 45.61 M | 3.41 M | 38.83 M | 37.28 M | 34.52 M | 31.49 M |
| R&D Expense | 14.63 M | 739.00 K | 11.55 M | 10.30 M | 10.00 M | 8.81 M |
| Operating Expenses | 60.24 M | 53.47 M | 50.38 M | 47.58 M | 44.52 M | 40.30 M |
| Operating Income | 3.55 M | -4.78 M | 3.28 M | -2.51 M | -4.34 M | -8.40 M |
| Pretax Income | 5.29 M | -2.97 M | 5.16 M | -3.18 M | -5.31 M | -9.45 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 5.29 M | -2.97 M | 5.16 M | -3.18 M | -5.31 M | -9.45 M |
| EPS (Basic) | 0.09 | -0.05 | 0.09 | -0.06 | -0.09 | -0.17 |
| EPS (Diluted) | 0.08 | -0.05 | 0.09 | -0.05 | -0.09 | -0.17 |
| Shares Outstanding | 59.69 M | 58.92 M | 58.43 M | 52.97 M | 57.32 M | 55.74 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.